The Division of Anatomic Pathology at the University of Alabama at Birmingham, offers a one-year fellowship experience in Genitourinary (GU) pathology. The University of Alabama at Birmingham (UAB) ...

NEW YORK, January 28, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology ...

Genitourinary cancers include prostate, bladder, kidney, and testicular cancers, with diagnosis involving imaging and biopsy. Treatment is personalized, involving surgery, radiation, chemotherapy, ...

Within the genitourinary cancer space, there have been many treatment advances over the past year. For patients with bladder cancer, exciting innovations in treatment have arrived, as we detail in ...

This study leverages CDC National Health Interview Survey data to examine financial distress (FD) among genitourinary (GU) cancer survivors, specifically prostate cancer (PC), kidney cancer (KC), and ...

The study included a total of 183 patients with genitourinary cancers. Immunity against SARS-CoV-2 appears to wane over time in genitourinary cancer patients following COVID-19 vaccination, suggesting ...

Although modern three-dimensional (3D) conformal radiotherapy has allowed to reach a total dose that increases local control with acceptable treatment toxicity, 1, 2 each of these treatments can ...

In a recent paper published in the American Journal of Clinical and Experimental Urology, researchers reviewed existing data on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...

More than 20 abstracts span Pfizer’s leading genitourinary cancer portfolio of approved standards of care and growing pipeline across prostate and bladder cancers Detailed overall survival (OS) ...